| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.009 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.009 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |